Coronavirus pandemic has infected over 10 million people worldwide with over half a million casualties. Countries worldwide are now easing the locked down restrictions to bring their economies back on track by allowing essential services and activities. With the ease in restrictions and lockdown measures the probability of spread of virus is expected to increase in the coming days.
The pharmaceutical and biotech companies are working round the clock to develop the effective and safe vaccine for Coronavirus. As of today, more than 150 candidate vaccines are in the preclinical and clinical evaluation phases.
Some of the front-runners in the Covid-19 vaccine developments includes:
-
Moderna (mRNA-1273)
-
AstraZeneca/Oxford (ChAdOx1 nCoV-19 /AZD1222)
-
CanSino Biologics Inc (Ad5-nCoV)
-
Inovio Pharmaceuticals (INO-4800)
-
Sinovac Life Sciences (CoronaVac)
The vaccine development rigorous research and testing process, the availability of safe & effective Covid-19 vaccine in the market is likely to take one and half years.
For more detailed information on COVID-19 Pipeline Analysis, visit: https://www.delveinsight.com/blog/coronavirus-vaccine-candidates/